KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

ClearPoint Neuro (CLPT) Income from Continuing Operations (2016 - 2026)

ClearPoint Neuro's Income from Continuing Operations history spans 13 years, with the latest figure at 7786000.0 for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations fell 44.56% to 7786000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 25540000.0, a 35.03% decrease, with the full-year FY2025 number at 25540000.0, down 35.03% from a year prior.
  • Income from Continuing Operations hit 7786000.0 in Q4 2025 for ClearPoint Neuro, down from 5891000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for CLPT hit a ceiling of 2513000.0 in Q1 2021 and a floor of 7786000.0 in Q4 2025.
  • Historically, Income from Continuing Operations has averaged 4888850.0 across 5 years, with a median of 4587500.0 in 2022.
  • Biggest five-year swings in Income from Continuing Operations: tumbled 174.41% in 2021 and later soared 38.19% in 2024.
  • Tracing CLPT's Income from Continuing Operations over 5 years: stood at 4146000.0 in 2021, then fell by 7.79% to 4469000.0 in 2022, then decreased by 5.3% to 4706000.0 in 2023, then decreased by 14.45% to 5386000.0 in 2024, then tumbled by 44.56% to 7786000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for CLPT at 7786000.0 in Q4 2025, 5891000.0 in Q3 2025, and 5837000.0 in Q2 2025.